rs503053

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.2345-68A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.373 in 1,535,320 control chromosomes in the GnomAD database, including 108,539 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.41 ( 12972 hom., cov: 32)
Exomes 𝑓: 0.37 ( 95567 hom. )

Consequence

COL4A1
NM_001845.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.520

Publications

6 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 13-110179104-T-C is Benign according to our data. Variant chr13-110179104-T-C is described in ClinVar as Benign. ClinVar VariationId is 1251073.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.508 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A1NM_001845.6 linkc.2345-68A>G intron_variant Intron 30 of 51 ENST00000375820.10 NP_001836.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A1ENST00000375820.10 linkc.2345-68A>G intron_variant Intron 30 of 51 1 NM_001845.6 ENSP00000364979.4 P02462-1

Frequencies

GnomAD3 genomes
AF:
0.408
AC:
61911
AN:
151872
Hom.:
12943
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.513
Gnomad AMI
AF:
0.559
Gnomad AMR
AF:
0.386
Gnomad ASJ
AF:
0.342
Gnomad EAS
AF:
0.300
Gnomad SAS
AF:
0.372
Gnomad FIN
AF:
0.351
Gnomad MID
AF:
0.304
Gnomad NFE
AF:
0.370
Gnomad OTH
AF:
0.405
GnomAD4 exome
AF:
0.369
AC:
510955
AN:
1383328
Hom.:
95567
Cov.:
22
AF XY:
0.369
AC XY:
254926
AN XY:
691386
show subpopulations
African (AFR)
AF:
0.520
AC:
16606
AN:
31932
American (AMR)
AF:
0.404
AC:
17195
AN:
42542
Ashkenazi Jewish (ASJ)
AF:
0.321
AC:
8192
AN:
25482
East Asian (EAS)
AF:
0.265
AC:
10317
AN:
38982
South Asian (SAS)
AF:
0.375
AC:
31374
AN:
83738
European-Finnish (FIN)
AF:
0.356
AC:
18635
AN:
52340
Middle Eastern (MID)
AF:
0.283
AC:
1360
AN:
4810
European-Non Finnish (NFE)
AF:
0.369
AC:
385800
AN:
1045828
Other (OTH)
AF:
0.372
AC:
21476
AN:
57674
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
17367
34733
52100
69466
86833
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12024
24048
36072
48096
60120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.408
AC:
62001
AN:
151992
Hom.:
12972
Cov.:
32
AF XY:
0.406
AC XY:
30142
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.514
AC:
21267
AN:
41410
American (AMR)
AF:
0.386
AC:
5911
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.342
AC:
1187
AN:
3466
East Asian (EAS)
AF:
0.300
AC:
1543
AN:
5144
South Asian (SAS)
AF:
0.373
AC:
1797
AN:
4818
European-Finnish (FIN)
AF:
0.351
AC:
3713
AN:
10578
Middle Eastern (MID)
AF:
0.296
AC:
87
AN:
294
European-Non Finnish (NFE)
AF:
0.370
AC:
25122
AN:
67964
Other (OTH)
AF:
0.410
AC:
865
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1880
3761
5641
7522
9402
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
590
1180
1770
2360
2950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.318
Hom.:
1255
Bravo
AF:
0.415
Asia WGS
AF:
0.381
AC:
1323
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
1.8
DANN
Benign
0.23
PhyloP100
-0.52
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs503053; hg19: chr13-110831451; API